The brain of cattle hydrolyzate (The brain of cattle hydrolyzate)

Pharmacodynamics Pharmacokinetics Indications Carefully Contraindications Dosing and Administration Side effects
Read on
Clinical and pharmacological group: & nbsp

Nootropics

Psychostimulants

Included in the formulation
АТХ:

N.06.B.X   Other psychostimulants and nootropic drugs

Pharmacodynamics:

The drug is a mixture of biologically active peptides, amino acids, which when injected potentiate the integrative processes in the central nervous system (enhance the resistance of nerve cells to hypoxia / hypoglycemia / intoxication, protein synthesis in neurons).

Pharmacokinetics:

Not described.

Indications:

Insufficiency of cerebral circulation, disruption of the cerebral cortex, discirculatory encephalopathy, asthenic syndrome, post-traumatic syndrome.

ICD-10

V.F00-F09.F07   Personality and behavioral disorders due to illness, damage or dysfunction of the brain

V.F90-F98.F90.0   Violation of activity and attention

VI.G60-G64.G60   Hereditary and idiopathic neuropathy

VI.G60-G64.G61   Inflammatory polyneuropathy

VI.G60-G64.G62.1   Alcoholic polyneuropathy

VI.G60-G64.G63.2 *   Diabetic polyneuropathy (E10-E14 + with common fourth sign .4)

VI.G80-G83.G80   Cerebral palsy

VI.G90-G99.G93.4   Encephalopathy, unspecified

VI.G90-G99.G95.9   Disease of spinal cord, unspecified

IX.I60-I69.I61   Intracerebral haemorrhage

IX.I60-I69.I63   Cerebral infarction

IX.I60-I69.I67.9   Cerebrovascular disease, unspecified

XIII.M50-M54.M54.1   Radiculopathy

XVIII.R47-R49.R47.8   Other and unspecified speech disorders

XVIII.R50-R69.R53   Malaise and fatigue

XIX.S00-S09.S06   Intracranial injury

XIX.T90-T98.T90.9   Consequences of Head Trauma, unspecified

XXI.Z70-Z76.Z73.6   Limitations of activities caused by a decrease or loss of ability to work

Contraindications:

Impaired renal function, hypersensitivity, status epilepticus, pregnancy.

Carefully:

Allergic reactions in the anamnesis, breast-feeding, epilepsy, pregnancy (I trimester).

Pregnancy and lactation:

The FDA category is not defined. Possible application during pregnancy and lactation under the supervision of a doctor.

Dosing and Administration:

Intramuscularly - 1-5 ml every day or every other day. Course - 20 injections. The course can be repeated in 3-6 months.

Neuropediatric practice: intramuscular 1-2 ml, course 10-15 days. The course can be repeated 2-3 times a year.

Side effects:

A slight increase in body temperature, increased blood pressure, irritation at the injection site.

Overdose:

Not described.

Interaction:

The drug enhances the effect of antidepressants.

Special instructions:

Does not affect the ability to drive vehicles or perform work where increased concentration is required.

Instructions
Up